Life Science Reit Share Discussion Threads

[chrisdgb] 28/3/2023 14:57

59p, is it really this bad...?

[jonwig] 23/3/2023 07:54

Report about shortage of lab space;



Trouble is, LABS isn't in a position to build anything.

[jonwig] 21/3/2023 10:50

Wasn't the "4%" based on the IPO price of 100p? (That's the usual way of saying these things.)

But if 4p isn't fully covered, it won't be so brilliant.

[saltwood] 21/3/2023 10:27

What will be interesting as we look forward to Monday’s results is, in addition to reassurance on the NAV and progress with OTP and reducing vacancy rates, is whether they stick to their dividend policy at IPO, namely a 4% dividend for year to Dec 2022. If so, we should be looking at a 3p per share dividend announced next week. Having re-read the results and listened again to a recent podcast from the investment manager, this trust appears to have done everything it said it would do at IPO and takes these commitments seriously. I am therefore really hopeful that the pain of recent months caused by broader market factors will be alleviated by a strong set of results next week. Here’s hoping!

[chrisdgb] 03/3/2023 08:21

Looks positive news on the debt this morning, hopefully push back through 70p level...

[chrisdgb] 02/3/2023 10:46

17th March I think, the fightback is on........

[chrisdgb] 28/2/2023 11:42

Hopefully when it goes into the SmallCap index there will be some tracker buying...

[jonwig] 27/2/2023 12:39

Needs to go to Specsavers🤔

[toffeeman] 27/2/2023 10:53

>> Jon

£150k per year

[jonwig] 27/2/2023 07:26

New 10yr lease signed at OTP:



No money details given, unfortunately.

Also FY results 27 March, with live audio provided of presentation:

[gbcol] 13/2/2023 17:00

I suspect that we will have to wait until end of March, when we get the results, before we see any significant upwards movement in share price At that point I am confident that NAV will be shown to be around the last published 102p (maybe higher with demand exceeding supply in the sector).

I had a little nibble again today and may well add a few more before March.

[jonwig] 13/2/2023 11:20

cheis - I don't think debt is a problem. LTV wass 9.5% at 30/06 last. Interest rate is capped, I think.

Like Col said, It's a head scratcher!

[chrisdgb] 13/2/2023 10:51

I assume there were some debt structure concerns with exposure to rising rates......

[gbcol] 13/2/2023 10:32

My instincts tell me I should be getting more of these but I already have a substantial holding (at a substantial loss) and that drop from over 90p to 70p was brutal and rather than recover like many others did, share price has continued to fall and I really don’t understand why.

[chrisdgb] 13/2/2023 10:22

Jefferies pushing the stock this morning, highlight the lag compared to peer group and 35% discount to nav, also the robust letting at Rolling Stock yard.........

[jonwig] 13/2/2023 07:21

Looks like my #76 was only half the story:

A lack of laboratory space in Oxford and Cambridge threatens to thwart Rishi Sunak’s dream of making Britain a “science superpower”.

In both cities, there are almost no labs left for growing life sciences businesses to move into. Bidwells, the commercial property agent, estimates that there is 10,000 sq ft of space available in Cambridge, compared with two million sq ft of demand. There is a similar picture in Oxford, where there is about 25,000 sq ft available compared with requirements from businesses of 845,000 sq ft.

Developers are rushing through new projects to try to catch up with demand.

More -

[gbcol] 10/2/2023 15:03

Divi should be half yearly, so next one will presumably be paid end April.

[orinocor] 10/2/2023 12:55

gbcol you are dead right about the lack of information. I don't even know if this pays a quarterly dividend or half yearly. Does anyone know?

[gbcol] 10/2/2023 09:29

Yes this was originally trading on AIM see RNS back in November re move to main market.

[aamhager] 10/2/2023 08:42

Are you saying this was trading on AIM at the beginning? Quite unusual for a REIT

[jonwig] 10/2/2023 08:24

The fall-out from Astra-Zeneca's announcement this week might have some effect. Other life science firms are warning that the UK is in danger of losing its self-proclaimed advantages by high corporation taxes.

LABS isn't a big enough player to be directly affected, I would think, but capital values might suffer and its NAV slip back.

[gbcol] 10/2/2023 08:12

I’ve emailed the company as I think the lack of updates is rather poor - last published NAV is 8 months out of date for example. Also I can’t see a list of major shareholders on their website.

I suspect we will have to wait until end of March when results are issued but I felt they needed a nudge. They may be content to sit back while the share price plummets but I’m not.

[gbcol] 10/2/2023 08:07

Re stamp duty, this is a result of the movement from AIM to the main market. Previously on AIM there wasn’t SD charged (that’s when I did most of my purchases) but now it is.

The move hasn’t provided us shareholders with any tangible benefits yet, that’s for sure.

[aamhager] 09/2/2023 16:59

Does it show stamp duty when you try to get a quote?